ICD-10 Coordination and Maintenance (C&M) Committee Meeting National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 11577-11578 [2017-03627]

Download as PDF 11577 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices in early intervention services before six months of age for those identified with hearing loss. Federal support for identifying children with hearing loss began with the Children’s Health Act of 2000, which authorized federal programs to support EHDI activities at the state level. Since then, funds have been distributed to states via cooperative agreements from the CDC and grants from the Health Resources and Services Administration (HRSA). States are using these federal monies to enhance EHDI programs and develop corresponding tracking and surveillance systems. These systems are intended to help EHDI programs ensure infants and children are receiving recommended hearing screening, follow-up, and intervention services. The mission of the CDC EHDI team is for every state and U.S. territory to have a complete EHDI tracking and surveillance system that will help ensure infants and children with hearing loss achieve communication and social skills commensurate with their cognitive abilities. As part of this mission the CDC EHDI team, in collaboration with representatives of state and U.S. territorial EHDI programs, developed seven National EHDI Goals that reflect the ‘‘1–3–6 plan’’ and address integration with the medical home (coordinated care by a medical provider) and development of tracking and surveillance systems to minimize loss to follow-up and loss to documentation. Many of the defined performance indicators for these goals involve obtaining data related to the number of children screened for hearing loss, referred for and receiving followup testing (e.g., diagnostic audiologic evaluation) and enrolled in early intervention services. The purpose of the revised survey is to obtain annual state data on the performance indicators in a consistent manner, which is needed to assess progress towards meeting the National EHDI goals. In addition, the availability of these data will better enable the CDC EHDI team to provide technical assistance to states and respond to questions by the general public, policy makers, and Healthy People 2020 officials. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name EHDI Program State Program Coordinators Contacted ......... EHDI Program State Program Coordinators who return the survey. Survey Directions ................... Survey .................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–03593 Filed 2–23–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK3SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOAs): CK17–001, ‘‘Creation of a Healthcare-Associated Infectious Disease Modeling Network to Improve Prevention Research and Healthcare Delivery’’; CK17–002, ‘‘Evaluation of Clinical Interventions, Surveillance, and Ecological Factors that Influence the Burden of Human Monkeypox in the Democratic Republic of the Congo (DRC)’’; and CK17–004, ‘‘Determining VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound Refugees.’’ Time and Date: 10:00 a.m.–5:00 p.m., EDT, March 28– 29, 2017 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Creation of a Healthcare-Associated Infectious Disease Modeling Network to Improve Prevention Research and Healthcare Delivery’’, CK17–001; ‘‘Evaluation of Clinical Interventions, Surveillance, and Ecological Factors that Influence the Burden of Human Monkeypox in the Democratic Republic of the Congo (DRC)’’, CK17–002; and ‘‘Determining and Monitoring Health Conditions Identified in the Medical Assessment of US-Bound Refugees’’, CK17–004. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Number of responses per respondent 59 57 Average burden per response (in hours) 1 1 10/60 240/60 Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–03647 Filed 2–23–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ICD–10 Coordination and Maintenance (C&M) Committee Meeting National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting ICD–10 Coordination and Maintenance (C&M) Committee meeting. TIME AND DATE: 9:00 a.m.–5:00 p.m., EST, March 7–8, 2017 NAME: E:\FR\FM\24FEN1.SGM 24FEN1 11578 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244 STATUS: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http:// www.cms.gov/live/. SECURITY CONSIDERATIONS: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend the March 7–8, 2017 ICD–10–CM C&M meeting must submit their name and organization by February 24, 2016 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend. Please register to attend the meeting on-line at: http://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786–4510 or Marilu.hue@ cms.hhs.gov), for questions about the registration process. PURPOSE: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10 Procedure Coding System. MATTERS FOR DISCUSSION: Agenda items include: March 7–8, 2017 ICD–10–PCS Topics: Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Renal Replacement Therapy Magnetically Controlled Growth Rods Oxidized Zirconium Polyethylene Implant for Hip and Knee Replacement Endovascular Intracranial Thrombectomy Procedures/Techniques Radiotherapeutic Brain Implant Combined Thoracic Arch Replacement and Thoracic Aorta Restriction Occlusion of Left Atrial Appendage Spinal Fusion with Radiolucent Interbody Fusion Device asabaliauskas on DSK3SPTVN1PROD with NOTICES PLACE: VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 Administration of ZINPLAVA (Bezlotoxumab) Administration of VYXEOS Administration of KTE–C19 (axicabtageneciloleucel) Congenital Anomaly Procedures Resection of the Left Ventricular Outflow Tract Obstruction and/or Subaortic Membrane(Stenosis) Fontan Completion Procedure, Stage II Alfieri Stitch Valvuloplasty Ligation of Pulmonary Trunk Fluoroscopy of Pulmonary Trunk Modified Blalock-Taussig Shunt Release of Myocardial Bridge Addenda and Key Updates ICD–10–CM Diagnosis Topics: Acute Appendicitis Antenatal Screening Asthma Atrial Fibrillation (AF) Cyclic Vomiting Diverticular Disease of Intestine Encounter for examination of eyes and vision with abnormal findings Fetal Inflammatory Response Syndrome Hepatic Encephalopathy (representation) Lacunar Infarction Meibomian Gland Dysfunction Neonatal Encephalopathy Glasgow Coma Scale, Pediatric Personal History of Mesothelioma and Secondary Mesothelioma Post Endometrial Ablation Syndrome Sickle Cell w/o Acute Chest Syndrome or Splenic Sequestration Surgical Site Infection Types of Myocardial Infarctions (MI) ICD–10–CM Addendum Agenda items are subject to change as priorities dictate. Note: CMS and NCHS no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/03_ meetings.asp#TopOfPage and http:// www.cdc.gov/nchs/icd/icd9cm_ maintenance.htm. CONTACT PERSONS FOR ADDITIONAL INFORMATION: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road Hyattsville, Maryland 20782, email dfp4@cdc.gov, telephone 301–458–4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland, 21244, email marilu.hue@ cms.hhs.gov, telephone 410–786–4510 (procedures). PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–03627 Filed 2–23–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of application in response to Funding Opportunity Announcement (FOA) PAR 15–361, NIOSH Centers of Excellence for Total Worker Health (TWH). Time and Date: 1:00 p.m.–6:00 p.m., EDT, March 21, 2017 (Closed). Place: Via Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘NIOSH Centers of Excellence for Total Worker Health (TWH)’’, PAR 15–361. Contact Person for More Information: Marilyn Ridenour, B.S.N., M.B.A., M.P.H., Scientific Review Officer, CDC, 1095 Willowdale Road, Mailstop 1811, Morgantown, WV Telephone: (304) 285– 5879, DVN7@CDC.GOV . The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11577-11578]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03627]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


ICD-10 Coordination and Maintenance (C&M) Committee Meeting 
National Center for Health Statistics (NCHS), Classifications and 
Public Health Data Standards Staff, Announces the Following Meeting

Name: ICD-10 Coordination and Maintenance (C&M) Committee meeting.

Time and Date: 9:00 a.m.-5:00 p.m., EST, March 7-8, 2017

[[Page 11578]]


Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244

Status: Open to the public, limited only by the space available. The 
meeting room accommodates approximately 240 people. We will be 
broadcasting the meeting live via Webcast at http://www.cms.gov/live/.

Security Considerations: Due to increased security requirements CMS has 
instituted stringent procedures for entrance into the building by non-
government employees. Attendees will need to present valid government-
issued picture identification, and sign-in at the security desk upon 
entering the building.
    Attendees who wish to attend the March 7-8, 2017 ICD-10-CM C&M 
meeting must submit their name and organization by February 24, 2016 
for inclusion on the visitor list. This visitor list will be maintained 
at the front desk of the CMS building and used by the guards to admit 
visitors to the meeting.
    Participants who attended previous Coordination and Maintenance 
meetings will no longer be automatically added to the visitor list. You 
must request inclusion of your name prior to each meeting you wish 
attend.
    Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or 
Marilu.hue@cms.hhs.gov), for questions about the registration process.

Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is a 
public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Tenth Revision, Clinical 
Modification and ICD-10 Procedure Coding System.

Matters for Discussion: Agenda items include:
March 7-8, 2017
ICD-10-PCS Topics:
    Cerebral Embolic Protection During Transcatheter Aortic Valve 
Replacement
    Renal Replacement Therapy
    Magnetically Controlled Growth Rods
    Oxidized Zirconium Polyethylene Implant for Hip and Knee 
Replacement
    Endovascular Intracranial Thrombectomy
    Procedures/Techniques
    Radiotherapeutic Brain Implant
    Combined Thoracic Arch Replacement and Thoracic Aorta Restriction
    Occlusion of Left Atrial Appendage
    Spinal Fusion with Radiolucent Interbody Fusion Device
    Administration of ZINPLAVA (Bezlotoxumab)
    Administration of VYXEOS
    Administration of KTE-C19 (axicabtageneciloleucel) Congenital 
Anomaly Procedures
    Resection of the Left Ventricular
    Outflow Tract Obstruction and/or Subaortic Membrane(Stenosis)
    Fontan Completion Procedure, Stage II
    Alfieri Stitch
    Valvuloplasty
    Ligation of Pulmonary Trunk
    Fluoroscopy of Pulmonary Trunk
    Modified Blalock-Taussig Shunt
    Release of Myocardial Bridge
    Addenda and Key Updates
ICD-10-CM Diagnosis Topics:
    Acute Appendicitis
    Antenatal Screening
    Asthma
    Atrial Fibrillation (AF)
    Cyclic Vomiting
    Diverticular Disease of Intestine
Encounter for examination of eyes and vision with abnormal findings
    Fetal Inflammatory Response Syndrome
    Hepatic Encephalopathy (re-presentation)
    Lacunar Infarction
    Meibomian Gland Dysfunction
    Neonatal Encephalopathy
    Glasgow Coma Scale, Pediatric
    Personal History of Mesothelioma and Secondary Mesothelioma
    Post Endometrial Ablation Syndrome
    Sickle Cell w/o Acute Chest Syndrome or Splenic Sequestration
    Surgical Site Infection
    Types of Myocardial Infarctions (MI)
    ICD-10-CM Addendum
    Agenda items are subject to change as priorities dictate.
    Note: CMS and NCHS no longer provide paper copies of handouts for 
the meeting. Electronic copies of all meeting materials will be posted 
on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage 
and http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.

Contact Persons for Additional Information:  Donna Pickett, Medical 
Systems Administrator, Classifications and Public Health Data Standards 
Staff, NCHS, 3311 Toledo Road Hyattsville, Maryland 20782, email 
dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue, Health 
Insurance Specialist, Division of Acute Care, CMS, 7500 Security 
Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov, 
telephone 410-786-4510 (procedures).
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-03627 Filed 2-23-17; 8:45 am]
 BILLING CODE 4163-18-P